DONATE TODAY
To Increase Patient Access

February 23, 2023

Learn About Next Generation Sequencing

EBCI logo on dark background

Advances in Precision Medicine NGS Testing, and Breaking the Barriers with Clinical Trials

Friday, May 12, 2023
5pm ET/ 2pm PT

Targeted therapies are a type of cancer treatment that targets proteins that control how cancer cells grow, divide, and spread. They are the foundation of precision medicine. As researchers learn more about the DNA changes and proteins that drive cancer, they are better able to design treatments that target these proteins. The purpose of this webinar is to provide an overview of current research of targeted therapies as demonstrated by the efforts of Endeavor Biomedicines; and hear from Oncology Nurses about what barriers they are seeing in the clinic.

This webinar on next generation sequencing is open to anyone interested in attending. We encourage Oncology Nurses, Navigation Nurses, Genetic Counselors, Oncologists, Patient Advocates / Caregivers and Patients to attend.

SPEAKERS

Photo of John Hood

John Hood
Chief Executive Officer,
Endeavor Biomedicines

Dellann photo

Dellann Elliott Mydland
President & Chair,
End Brain Cancer Initiative

Anita DiFrancesco

Anita DiFrancesco
VP, Clinical Operations, Endeavor BioMedicines

ENDBRAINCANCER INITIATIVE | CHRIS ELLIOTT FUND

Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
DONATE
corporate partners
upcoming events
resources
About us
envelopephonemap-markerpointer-right
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram